Boston, MA - Patients who receive high doses of the antidepressants citalopram or escitalopram could potentially develop QT-interval prolongation, a marker of a slight increased risk for ventricular ...

Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations.

For many years, moderate alcohol intake and its effect on health have been subject to much debate, particularly concerning cardiovascular health. Indeed, light-to-moderate use of alcohol has been ...

There were 252 patients with EKG results included for the analysis; they were given concomitant therapy for median 7 days. This article is written live from ID Week 2017 Annual Meeting in San Diego, ...

Silver Spring, MD - The FDA's Cardiovascular and Renal Drugs Advisory Committee has ruled that the clinical trials conducted by Bayer/GlaxoSmithKline for its erectile dysfunction drug, vardenafil ...

Plausible explanations for differences in the prognostic impact of prolonged QTc interval among the studies are the occurrence of chance, bias and uncontrolled confounding variables. Chance could have ...

Arsenic trioxide (ATO) is a highly effective agent for the treatment of acute promyelocytic leukemia (APL). QT interval prolongation is common with ATO and can pose a barrier to effective ...

Please provide your email address to receive an email when new articles are posted on . For more than a decade, numerous studies have reported that macrolide and fluoroquinolone antibiotics have been ...

Effect of food on the pharmacokinetics (PK) of olaparib after oral dosing of the capsule formulation. Results of a phase I trial combining ridaforolimus (mTOR inhibitor) and MK-0752 (Notch inhibitor) ...

The QT interval is the time from the beginning of the QRS complex (ventricular depolarization) to the end of the T wave (ventricular repolarization). The normal QT interval is controversial and ...

Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.

As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...